Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer
- 20 April 2020
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 33 (9), 1802-1810
- https://doi.org/10.1038/s41379-020-0543-y
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Best Practices Recommendations in the Application of Immunohistochemistry in the Bladder LesionsThe American Journal of Surgical Pathology, 2014
- Best Practices Recommendations in the Application of Immunohistochemistry in the ProstateThe American Journal of Surgical Pathology, 2014
- Pseudopapillary Features in Prostatic Adenocarcinoma Mimicking Urothelial CarcinomaThe American Journal of Surgical Pathology, 2014
- Aggressive Variants of Castration-Resistant Prostate CancerClinical Cancer Research, 2014
- Utility of GATA3 Immunohistochemistry in Differentiating Urothelial Carcinoma From Prostate Adenocarcinoma and Squamous Cell Carcinomas of the Uterine Cervix, Anus, and LungThe American Journal of Surgical Pathology, 2012
- ERG gene rearrangements are common in prostatic small cell carcinomasLaboratory Investigation, 2011
- Aberrant Diffuse Expression of p63 in Adenocarcinoma of the Prostate on Needle Biopsy and Radical Prostatectomy: Report of 21 CasesThe American Journal of Surgical Pathology, 2008
- Immunohistochemical Differentiation of High-grade Prostate Carcinoma From Urothelial CarcinomaThe American Journal of Surgical Pathology, 2007
- Prostate Carcinoma With Squamous DifferentiationThe American Journal of Surgical Pathology, 2004
- Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progressionCancer, 1993